全文获取类型
收费全文 | 20611篇 |
免费 | 2748篇 |
国内免费 | 1125篇 |
专业分类
耳鼻咽喉 | 102篇 |
儿科学 | 206篇 |
妇产科学 | 180篇 |
基础医学 | 2880篇 |
口腔科学 | 393篇 |
临床医学 | 1906篇 |
内科学 | 2630篇 |
皮肤病学 | 259篇 |
神经病学 | 1893篇 |
特种医学 | 217篇 |
外国民族医学 | 5篇 |
外科学 | 1281篇 |
综合类 | 3042篇 |
现状与发展 | 3篇 |
预防医学 | 855篇 |
眼科学 | 418篇 |
药学 | 3913篇 |
19篇 | |
中国医学 | 2286篇 |
肿瘤学 | 1996篇 |
出版年
2024年 | 222篇 |
2023年 | 775篇 |
2022年 | 1368篇 |
2021年 | 1640篇 |
2020年 | 1471篇 |
2019年 | 1028篇 |
2018年 | 974篇 |
2017年 | 996篇 |
2016年 | 1072篇 |
2015年 | 1032篇 |
2014年 | 1511篇 |
2013年 | 1818篇 |
2012年 | 1422篇 |
2011年 | 1359篇 |
2010年 | 883篇 |
2009年 | 853篇 |
2008年 | 748篇 |
2007年 | 700篇 |
2006年 | 547篇 |
2005年 | 478篇 |
2004年 | 387篇 |
2003年 | 344篇 |
2002年 | 237篇 |
2001年 | 237篇 |
2000年 | 191篇 |
1999年 | 178篇 |
1998年 | 163篇 |
1997年 | 156篇 |
1996年 | 141篇 |
1995年 | 123篇 |
1994年 | 122篇 |
1993年 | 122篇 |
1992年 | 106篇 |
1991年 | 98篇 |
1990年 | 75篇 |
1989年 | 71篇 |
1988年 | 92篇 |
1987年 | 71篇 |
1986年 | 70篇 |
1985年 | 81篇 |
1984年 | 75篇 |
1983年 | 61篇 |
1982年 | 74篇 |
1981年 | 64篇 |
1980年 | 52篇 |
1979年 | 32篇 |
1978年 | 35篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1973年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
Binding of a specific dopamine D1 receptor antagonist,125I-SCH 23982, was measured in rat brain sections by quantitative autoradiography at various time intervals, following a knife cut through the striatonigral pathway. Twenty-four hours after lesioning, accumulations of D1 receptor binding sites were found in sagittal sections both rostral and caudal to the lesion site. No other regions studied (caudate-putamen, nucleus accumbens, olfactory tubercle, and substantia nigra pars reticulata) showed any change in D1 receptor binding 24h after the lesion. In brain sections obtained 10 days after lesioning, only the substantia nigra pars reticulata had a significant decrease in D1 receptors ipsilateral to the lesion. These findings suggest the possibility of a presence of bidirectional axonal transport of D1 receptors in rat striatonigral pathway. 相似文献
52.
The effects of anesthesia on otoacoustic emissions 总被引:4,自引:0,他引:4
Noam Harel Akinobu Kakigi Haruo Hirakawa Richard J. Mount Robert V. Harrison 《Hearing research》1997,110(1-2):25-33
We have measured transient-evoked and distortion-product otoacoustic emissions (OAEs) in the chinchilla and compared them in the awake and anesthetized animal (using either ketamine or barbiturate agents). We report a significant increase in OAE amplitudes during anesthesia, particularly using ketamine. These effects are most evident for transient-evoked otoacoustic emissions (TEOAEs) as measured in the non-linear mode. Our data support the hypothesis that tonic activity levels in cochlear efferents may be reduced by anesthetic effects, either directly or indirectly (e.g., by general reductions in descending pathway activity), and that reduced cochlear efferent activity will result in the observed increase of OAE amplitudes. 相似文献
53.
Does the nature of the solvent affect the anti-inflammatory capacity of triclosan? An experimental study 总被引:4,自引:0,他引:4
Anne B. Skaare Vibeke Kjærheim Pål Barkvoll Gunnar Rölla 《Journal of clinical periodontology》1997,24(2):124-128
Abstract The anti-inflammatory properties of triclosan have been revealed in several recent studies, including an effect on histamine-induced inflammation. In other studies, the nature of the solvent has been shown to be of importance for the plaque inhibiting as well as the antibacterial potential of triclosan. This study was aimed at examining whether the nature of the solvent also may influence the anti-inflammatory capacity of triclosan and further to study a possible dose/response relationship. The study was performed as 3 separate, double-blind experiments, comprising 10, 11 and 12 healthy females. In all 3 experiments, 5 sites on the lower part of the back of the volunteers were intradermally exposed to one drop of 1% histamine dihydrochloride for 15 min. The size of the resulting wheals was recorded before and after 40 min of triclosan treatment. In experiment I. 4 different concentrations of triclosan in 2-fold dilutions in absolute alcohol (0.125%-1%) were applied on the histamine-induced wheals. In experiments 2 and 3, 4 different solutions containing 0.5% triclosan and a saline solution as negative control were used. The solvents in experiment 2 were as follows: (1) absolute alcohol (positive control). (2) propylene glycol (PG), (3) polyethylene glycol (PEG). (4) olive oil, and in experiment 3: (1) absolute alcohol (positive control). (2) Tween 80. (3) sodium carbonate, (4) soy oil. The results showed a dose/ response effect of triclosan and further that the solvent may be of importance for its anti-inflammatory potential. 相似文献
54.
P C G?tzsche 《Journal of clinical epidemiology》1990,43(12):1313-1318
In a meta-analysis of placebo controlled NSAID trials, the sensitivity of the effect variables was calculated as the correlation coefficient and as the difference between drug and placebo, divided by the placebo group standard deviation. The patient's global evaluation was the most sensitive variable overall. Pain was more sensitive than Ritchie's index. Several variables may be omitted from clinical trials, especially if two active drugs are being compared. For example, the best maximum estimate for the difference in ESR between NSAADs and placebo was 1.0 mm/hr (95% confidence interval −1.5 to 3.4 mm/hr), and for joint size 0.44% (−1.0 to 1.9%), corresponding to a quarter of a millimeter for each of the 10 joints usually measured. It is suggested to record only the patient's global evaluation, pain, and morning stiffness. 相似文献
55.
M. P. Nieto-Bona L. M. Garcia-Segura I. Torres-Aleman 《Journal of neuroscience research》1993,36(5):520-527
Insulin-like growth factor I (IGF-I) and its receptor are expressed in functionally related areas of the rat brain such as the inferior olive and the cerebellar cortex. A marked decrease of IGF-I levels in cerebellum is found when inferior olive neurons are lesioned. In addition, Purkinje cells in the cerebellar cortex depend on this growth factor to survive and differentiate in vitro. Thus, we consider it possible that IGF-I forms part of a putative trophic circuitry encompassing the inferior olive and the cerebellar cortex and possibly other functionally connected areas. To test this hypothesis we have studied whether IGF-I may be taken up, transported, and released from the inferior olive to the cerebellum. We have found that 125I-IGF-I is taken up by inferior olive neurons in a receptor-mediated process and orthogradely transported to the cerebellum. Thus, radioactivity found in the cerebellar lobe contralateral to the injection site in the inferior olive was immunoprecipitated by an anti-IGF-I antibody, co-eluted with 125I-IGF-I in an HPLC column, and co-migrated with 125I-IGF-I in an SDS-urea polyacrylamide gel electrophoresis. Time-course studies indicated that orthograde axonal transport is relatively rapid since 30 min after the injection, radiolabeled IGF-I was already detected in the contralateral cerebellum. Furthermore, transport of IGF-i from the inferior olive is specific since when 125I-neurotensin was injected in the inferior olive or when 125I-IGF-I was injected in the pontine nucleus, no radiactivity was found in the contralateral cerebellum. In addition, no specific transport of 125I-IGF-I was found in climbing fiber-deafferented rats or when excess unlabeled IGF-I was co-injected with 125I-IGF-I. We next studied whether IGF-I is released by inferior olive neurons. We found that the release of IGF-I from cerebellar slices of normal rats was significantly greater in response to depolarizing stimuli than that from slices obtained of climbing fiber-deafferented animals. Indeed, in vitro release of IGF-I in response to KCI or veratridine was almost completely abolished in the latter. These data suggest that IGF-I is taken up by inferior olive neurons through IGF-I receptors and transported to the cerebellum through their axons without any major modification. Moreover, the release of IGF-I from the cerebellum after depolarization depends on the presence of climbing fiber afferents. Altogether these results indicate that the olivo-cerebellar pathway is able to take up, orthogradely transport, and release IGF-I. Since a similar process has been described in the visual system for basic fibroblast growth factor (bFGF), we propose that IGF-I, bFGF, and possibly other growth factors may constitute afferent trophic signals involved in plastic mechanisms within specific neural circuitries. © 1993 Wiley-Liss, Inc. 相似文献
56.
本文报告两例持续性交界区反复性心动过速(PJRT)患者,应用导管射频消融术治疗,成功地阻断了位于后间隔具有递减传导特性的稳若旁路.随访7~10个月.病人无心动过速发作,提示导管射频消融术是治疗PJRT的有效方法. 相似文献
57.
The distribution patterns of choline acetyltransferase (CAT), as a marker for cholinergic neurons, and Calbindin-D28k (CaBP) immunoreactivities in the forebrain basal ganglia of the Japanese monkeyMacaca fuscata were compared. Similar distribution patterns of CAT and CaBP immunoreactivities were found in the medial septal nucleus (MS) and the nucleus of the diagonal band of Broca (DBB). Double-labeling fluorescence immunocytochemistry revealed that most, but not all, cholinergic neurons were CaBP-immunoreactive in the MS and DBB. The results suggest that CaBP may play a role in the septohippocampal cholinergic neuron system of the monkey. 相似文献
58.
急性冠脉综合征(ACS)是冠心病的严重类型,ACS患者不仅病死率较高,还存在缺血事件(如缺血性卒中、心肌梗死)复发风险。血小板聚集及血栓形成是导致ACS的重要原因。为降低缺血事件的发生风险,临床推荐ACS患者接受阿司匹林联合强效P2Y12抑制剂的双联抗血小板治疗12个月。然而在标准双联抗血小板治疗下,ACS患者残余缺血风险(经抗栓治疗后仍残留的缺血事件发生风险)仍旧较高。因此为进一步降低缺血事件发生风险,临床对强化抗栓方案的研究也逐渐增多。本文通过总结强化抗栓治疗方案的作用机制及其最新研究进展,发现延长双联抗血小板治疗时间、三联抗血小板治疗、双通道抑制(抗血小板联合抗凝治疗)等强化抗栓治疗方案可降低缺血事件发生风险,为进一步指导临床个体化抗栓治疗及明确最佳抗栓策略提供了参考。 相似文献
59.
目的 探讨血管紧张素转化酶2(ACE2)对缺氧复氧诱导的肾小管上皮细胞HK-2氧化应激、炎症、凋亡及核因子E2相关因子2(Nrf2)/血红素加氧酶1(HO-1)信号通路的影响。 方法 将ACE2慢病毒转染HK-2细胞,按照实验需要分为常氧组(Control组)、缺氧复氧模型组(H/R组)、缺氧复氧转染阴性对照慢病毒组(H/R-NC组)和缺氧复氧转染ACE2慢病毒组(H/R-ACE2组)。细胞经H/R处理后,通过CCK-8法检测细胞活力;RT-PCR及ELISA法检测炎症因子白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和白介素-1β(IL-1β)水平;比色法检测超氧化物歧化酶(SOD)、丙二醛(MDA)表达水平;Western blotting法检测胱天蛋白酶3(Caspase-3)、B淋巴细胞瘤-2基因(Bcl-2)、Bcl-2关联X蛋白(Bax)、Nrf2、HO-1的蛋白水平。采用Nrf2抑制剂ML385以及HO-1抑制剂SnPPIX抑制Nrf2/HO-1通路,Western blotting法检测Caspase-3、Bcl-2、Bax、Nrf2、HO-1的蛋白表达水平变化,比色法检测SOD和MDA表达变化。 结果 与Control组相比,H/R组细胞活力降低(t=7.58,P<0.001),MDA含量和炎症因子IL-6、TNF-α和IL-1β表达水平以及细胞凋亡相关蛋白Caspase-3、Bax蛋白水平均增加(tMDA=11.08,PMDA<0.001;tPCR-IL-6=5.82,PPCR-IL6<0.001;tPCR-TNF-α=7.69,PPCR-TNF-α<0.001;tPCR-IL-1β=4.80,PPCR-IL-1β=0.001;tELISA-IL-6=34.11,PELISA-IL-6<0.001;tELISA-TNF-α=14.12,PELISA-TNF-α<0.001;tELISA-IL-1β=9.63,PELISA-IL-1β<0.001;tCaspase-3=2.73,PCaspase-3=0.026;tBax=27.75,PBax<0.001),SOD活性、Bcl-2和ACE2蛋白水平下降(tSOD=7.74,PSOD<0.001;tBcl-2=75.49,PBcl-2<0.001;tACE2=11.41,PACE2<0.001)。与H/R组相比,H/R-ACE2组细胞活力增加(t=3.61,P=0.002),MDA含量和炎症因子IL-6、TNF-α和IL-1β表达水平以及细胞凋亡相关蛋白Caspase-3、Bax蛋白水平均下降(tMDA=6.15,PMDA<0.001;tPCR-IL-6=3.34,PPCR-IL-6=0.006;tPCR-TNF-α=3.65,PPCR-TNF-α=0.007;tPCR-IL-1β=4.06,PPCR-IL-1β=0.004;tELISA-IL-6=14.62,PELISA-IL-6<0.001;tELISA-TNF-α=10.42,PELISA-TNF-α<0.001;tELISA-IL-1β=8.65,PELISA-IL-1β<0.001;tCaspase-3=3.74,PCaspase-3=0.006;tBax=30.52,PBax<0.001),SOD活性、Bcl-2和ACE2蛋白水平增加(tSOD=3.58,PSOD=0.007;tBcl-2=63.86,PBcl-2<0.001;tACE2=58.72,PACE2<0.001),Nrf2/HO-1信号通路被激活蛋白水平增加(tNrf2=44.55,PNrf2<0.001;tHO-1=14.19,PHO-1<0.001)。然而ML385和SnPPIX处理会抑制ACE2基因过表达在H/R中HK-2细胞的保护作用(FBax=11.02,PBax=0.003;FBcl-2=21.48,PBcl-2<0.001;FCaspase-3=20.80,PCaspase-3<0.001;FSOD=133.49,PSOD<0.001;FMDA=14.06,PMDA=0.001)。 结论 ACE2在HK-2细胞缺氧复氧损伤中具有抑制氧化应激、调节炎症、改善凋亡的作用,Nrf2/HO-1信号通路发挥重要作用。 相似文献
60.
Summary In vivo prostatic secretion was collected from retired breeder Sprague Dawley rats using a method for isolated perfusion of the rat prostatic urethra. Enzymatic acid phosphatase determination was performed on the collected effluent. Control acid phosphatase secretion was 24.2±2.7 nm over 30 minutes. Intravenous phenylephrine 5 mg/kg stimulated a 10 fold increase in acid phosphatase secretion. The secretion seen with phenylephrine was dose dependent and could be blocked with prazosin, but not yohimbine, atropine, or propranolol. Intravenous -adrenergic agonist isoproterenol caused no increase in the secretion of rat prostatic acid phosphatese. Intravenous administration of the cholinergic agonist pilocarpine also resulted in a dose dependent rise in acid phosphatase secretion. The stimulation seen could be blocked by atropine but not phentolamine or propranolol. The stimulation of acid phosphatase secretion seen with 1 adrenergic or cholinergic agonists was not additive. Intravenous vasoactive intestinal peptide did not stimulate acid phosphatase secretion nor did it augment the secretion induced by 1 adrenergic or cholinergic agonists. Release of acid phosphatase into rat prostatic exocrine secretion is under both 1 adrenergic and cholinergic control.Supported by the US Veterans Administration 相似文献